OESOPHAGEAL NEOPLASM

OESOPHAGEAL NEOPLASM was reported 185 times

OESOPHAGEAL NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 1 0.0006
1 Provitamin D2 Compound [EPC] 5 0.0002
2 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
3 Cannabinoid [EPC] 1 0.0001
4 Quinolone Antimicrobial [EPC] 1 0.0001
5 Interleukin-17A Antagonist [EPC] 3 0.0001
6 Cholinesterase Inhibitor [EPC] 1 0.0001
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
8 Pyridone [EPC] 2 0.0000
9 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
10 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1 0.0000
11 Radiographic Contrast Agent [EPC] 1 0.0000
12 Macrolide Antimicrobial [EPC] 2 0.0000
13 Methylxanthine [EPC] 2 0.0000
14 Iron Chelator [EPC] 1 0.0000
15 P2Y12 Platelet Inhibitor [EPC] 4 0.0000
16 Phenothiazine [EPC] 1 0.0000
17 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
18 Expectorant [EPC] 6 0.0000
19 Interleukin-23 Antagonist [EPC] 3 0.0000
20 Proton Pump Inhibitor [EPC] 15 0.0000
21 Sulfonylurea [EPC] 3 0.0000
22 Thiazide Diuretic [EPC] 5 0.0000
23 Nucleoside Analog Antiviral [EPC] 2 0.0000
24 Thiazide-like Diuretic [EPC] 1 0.0000
25 Fluoroquinolone Antibacterial [EPC] 3 0.0000
26 Vitamin D [EPC] 7 0.0000
27 Nitrate Vasodilator [EPC] 2 0.0000
28 Protease Inhibitor [EPC] 1 0.0000
29 Vitamin C [EPC] 9 0.0000
30 Insulin [EPC] 1 0.0000
31 Vitamin B12 [EPC] 7 0.0000
32 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
33 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
34 Osmotic Laxative [EPC] 6 0.0000
35 Calcium [EPC] 3 0.0000
36 Antirheumatic Agent [EPC] 2 0.0000
37 Benzodiazepine [EPC] 13 0.0000
38 Anti-epileptic Agent [EPC] 4 0.0000
39 Parathyroid Hormone Analog [EPC] 2 0.0000
40 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
41 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
42 Platelet Aggregation Inhibitor [EPC] 9 0.0000
43 Interferon beta [EPC] 3 0.0000
44 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
45 Platinum-based Drug [EPC] 4 0.0000
46 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
47 Factor Xa Inhibitor [EPC] 4 0.0000
48 Tetracycline-class Drug [EPC] 1 0.0000
49 Potassium Channel Blocker [EPC] 1 0.0000
50 Cardiac Glycoside [EPC] 1 0.0000
51 Mood Stabilizer [EPC] 3 0.0000
52 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
53 Thalidomide Analog [EPC] 7 0.0000
54 HER2/neu Receptor Antagonist [EPC] 1 0.0000
55 Atypical Antipsychotic [EPC] 6 0.0000
56 Nonsteroidal Anti-inflammatory Drug [EPC] 17 0.0000
57 Aldosterone Antagonist [EPC] 2 0.0000
58 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
59 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
60 Janus Kinase Inhibitor [EPC] 2 0.0000
61 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
62 Integrin Receptor Antagonist [EPC] 1 0.0000
63 Anti-IgE [EPC] 1 0.0000
64 Central Nervous System Stimulant [EPC] 1 0.0000
65 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
66 Corticosteroid [EPC] 14 0.0000
67 Purine Antimetabolite [EPC] 1 0.0000
68 Acetylcholine Release Inhibitor [EPC] 1 0.0000
69 Antiarrhythmic [EPC] 1 0.0000
70 Endothelin Receptor Antagonist [EPC] 2 0.0000
71 beta-Adrenergic Blocker [EPC] 3 0.0000
72 Interleukin-12 Antagonist [EPC] 1 0.0000
73 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
74 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
75 Tumor Necrosis Factor Blocker [EPC] 9 0.0000
76 Aromatase Inhibitor [EPC] 1 0.0000
77 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
78 Opioid Agonist [EPC] 2 0.0000
79 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
80 Prostacycline Vasodilator [EPC] 1 0.0000
81 Kinase Inhibitor [EPC] 4 0.0000
82 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
83 alpha-Adrenergic Blocker [EPC] 1 0.0000
84 Loop Diuretic [EPC] 3 0.0000
85 Interleukin-4 Receptor alpha Antagonist [EPC] 3 0.0000
86 Estrogen [EPC] 1 0.0000
87 RANK Ligand Inhibitor [EPC] 1 0.0000
88 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000